Drinking fermented milk
Dietary SupplementDrinking fermented milk containing Lactobacillus paracasei (IMULUS)
NCT Number: NCT02909842
This blinded randomized controlled trial aims to investigate the effect of drinking fermented milk containing Lactobacillus paracasei (IMULUS) on immune response against influenza.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Not applicable
This study is conducted in healthy volunteer using product approved by Thai FDA. This blinded randomized controlled trial compare immune response against influenza H1N1, H3N2 and Phu-B between study group and control group. The study group receives influenza vaccine and drinking fermented milk containing Lactobacillus paracasei (IMULUS), while the control group receives influenza vaccine and placebo acidified milk. The trial lasts for 8 weeks and include four time points of data collection (0, 2, 6, 8 weeks). Subjects, outcome assessor and investigators are blinded throughout the study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Drinking fermented milk containing Lactobacillus paracasei (IMULUS)
Acidified placebo milk with similar physical characteristics to the yoghurt drink
Intramuscular injection of a single shot of influenza vaccine
Time frame: 4 weeks after vaccination
Number of subjects with increased HAI titer from baseline divided by total number of subjects
Time frame: 4 weeks after vaccination
Number of subjects with increased Immunoglobulin G or M (IgG or IgM) antibody levels from baseline divided by total number of subjects
Time frame: 0, 2, 6 and 8 weeks after baseline
Changes in serum levels of IgM antibody against influenza A, detected by ELISA assay
Time frame: 0, 2, 6 and 8 weeks after baseline
Changes in serum levels of IgG antibody against influenza A, detected by ELISA assay
Time frame: 0, 2, 6 and 8 weeks after baseline
Changes in maximum dilution of serum, detected by Heme agglutination inhibition (HAI) assay , which can immunologically react against H1N1, H3N2 and Phu-B virus
Mahidol University
Other
Immunomodulating Effects of Drinking Fermented Milk Containing Lactobacillus Paracasei (IMULUSTM): a Randomized Controlled Trial Using an Influenza Vaccination Model
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04794829
COVID-19, Coronaviridae Infections
Bethesda, Maryland, United States
View Trial DetailsNCT07737106
Infections, Influenza
Bayan Nur, Inner Mongolia, China
View Trial DetailsNCT06518577
Infections, Influenza
Phoenix, Arizona, United States
View Trial DetailsNCT06560151
Infections, Influenza
Atlanta, Georgia, United States
View Trial Details